What is the ticker symbol for Leap Therapeutics?

Leap Therapeutics trades under the ticker LPTX on NASDAQ.

What sector does Leap Therapeutics operate in?

Leap Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LPTX in a portfolio?

PortView shows LPTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Leap Therapeutics (LPTX) Stock Analysis

NASDAQHealthcareBiotechnology

$0.77-3.15%

1-year price historyRange $0.24 – $2.97

52-week range$0.77

$0.22$3.58

What Leap Therapeutics does

Leap Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing treatments for various cancers. At the forefront of its pipeline is DKN-01, a monoclonal antibody designed to block Dickkopf-related protein 1 (DKK1). This investigational therapy is currently undergoing several clinical trials, targeting a range of malignancies such as esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics has also forged an option and licensing partnership with BeiGene, Ltd., granting them rights to develop and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Established in 2011, the company initially operated as HealthCare Pharmaceuticals, Inc., before rebranding to Leap Therapeutics, Inc. in November 2015. Its corporate headquarters are situated in Cambridge, Massachusetts.

Key metrics

Market cap

$31.86M

P/E (TTM)

-0.49

EPS (TTM)

$-1.58

Beta

0.09

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.71

200-day avg

$0.45

52-week high

$3.58

52-week low

$0.22

CEO

Douglas E. Onsi

ETFs linked to LPTX

Broad-market and Healthcare sector ETFs an investor holding Leap Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LPTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LPTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Leap Therapeutics?: Leap Therapeutics trades under the ticker LPTX on NASDAQ.
Which exchange is LPTX listed on?: LPTX is listed on NASDAQ.
What sector does Leap Therapeutics operate in?: Leap Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LPTX in a portfolio?: PortView shows LPTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.